S 4327 · 119th Congress ·
A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2026-04-16)
Plain Language Summary
No summary available yet for this bill.
Summarized by Claude AI · Non-partisan · For informational purposes only